Abstract

Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags

Author(s): Kaiser Jeanette, Kramer Irene

Issue: Nov/Dec 2011 - Volume 15, Number 6

Page(s): 515-520

Download in electronic PDF format for $75
  • Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Page 1
  • Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Page 2
  • Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Page 3
  • Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Page 4
  • Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Page 5
  • Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Page 6

Abstract

The purpose of this study was to determine the physicochemical stability of ready-to administer trastuzumab infusion solutions in 0.9% sodium chloride solution as the vehicle over a prolonged period of 28 days. Trastuzumab lyophilized powder was reconstituted with water for injection to a nominal concentration of 21 mg/mL. The reconstituted trastuzumab concentrate was further diluted with 0.9 % sodium chloride solution in polypropylene infusion bags. The physicochemical stability of the infusion solutions was assessed over a four-week storage period. Test solutions were stored under refrigeration (2°C to 8°C) or at room temperature under light protection and exposed to light. Samples of test solutions were withdrawn on day 0 (initial), 1, 3, 7, 14, 21, and 28. Preparation of the test solutions and sampling were conducted under aseptic conditions. Stability of trastuzumab infusion solutions was determined by size-exclusion high-performance liquid chromatography, ultraviolet-visible spectrometry, and sodium dodecyl sulphate polyacrylamide gel electrophoresis. In addition, pH values were measured weekly over the storage period, and test solutions were visually examined for potential color changes, turbidity, or particulate matter. The stability tests used revealed that in ready-to administer trastuzumab infusion solutions (0.4 mg/mL, 4 mg/mL) trastuzumab concentrations remained above 90% of the initial concentrations, independent of the storage conditions. No degradation products were observed. Exposure to daylight did not affect the stability of the trastuzumab test solutions. Readyto-administer trastuzumab infusion solutions prepared with 0.9% sodium chloride solution in polypropylene bags are storable over a four-week period, even when stored at room temperature without light protection. For microbiological reasons, storage under refrigeration is recommended.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2011
Pg. 515-520
Mar/Apr 2002
Pg. 152-154
Jul/Aug 2018
Pg. 345-349
Sep/Oct 2015
Pg. 432-436
Mar/Apr 2006
Pg. 156-158
Mar/Apr 2011
Pg. 94-100
Author(s): Miron Karen E
May/Jun 2003
Pg. 170-174
Author(s): Meece Jerry
Jul/Aug 2021
Pg. 330-335
May/Jun 2011
Pg. 252-254
May/Jun 2003
Pg. 230-232
May/Jun 2002
Pg. 226-229
Sep/Oct 2018
Pg. 417-423
May/Jun 2021
Pg. 246-257
Mar/Apr 2004
Pg. 156-159
Jul/Aug 2000
Pg. 281-285
Author(s): Ashworth Lisa D
Sep/Oct 2017
Pg. 436-439
Sep/Oct 2010
Pg. 436-439
Jan/Feb 2006
Pg. 69-73
Nov/Dec 2017
Pg. 481-486
Author(s): Allen Loyd V Jr
Sep/Oct 2019
Pg. 434-437